The inhibition of experimentally induced visceral hyperalgesia by nifedipine - A voltage-gated Ca2+ channels blocker (VGCCs) in Sheep

Research in Veterinary Science

Volumn 86, Issue 2, 2009, Pages 285-292

  Kania, B F ^a   Kowalczyk, M ^b   Brytan, M ^b   Tomaszewska, D ^c   Przekop, F ^c  

^a Veterinary Medicine Faculty   (Poland)

^b MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Behavioral changes; Central effects of nifedipine; Cortisol and catecholamine changes in the blood plasma; Duodenal distension

Indexed keywords

ADRENALIN; CALCIUM ION; CATECHOLAMINE; DIHYDROSTREPTOMYCIN; DOPAMINE; KETAMINE; NEUROTRANSMITTER; NIFEDIPINE; NORADRENALIN; PREDNISOLONE ACETATE; PROCAINE PENICILLIN; VOLTAGE GATED CALCIUM CHANNEL;

ADRENALIN BLOOD LEVEL; ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CALCIUM TRANSPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DUODENUM DISEASE; EXCITABILITY; FEMALE; HYPERALGESIA; HYPERVENTILATION; INTESTINE CONTRACTION; INTESTINE MOTILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; NORADRENALIN BLOOD LEVEL; SHEEP; SYMPTOM; TACHYCARDIA; VISCERAL PAIN;

ABDOMINAL PAIN; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CATECHOLAMINES; FEMALE; GASTROINTESTINAL MOTILITY; HEART RATE; NIFEDIPINE; RESPIRATION; SHEEP;

ANIMALIA; OVIS ARIES;

EID: 60249094715     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.04.010     Document Type: Article

References (50)

1. 2+ channels. Brain Res. Dev. Brain Res. 94 (1996) 182-189
2. 2+ signaling requirements. Biochem. J. 337 (1999) 153-169
3. 2+ channels subtypes mediating GABA-ergic transmission in the rat supraoptic nucleus. Eur. J. Neurosci. 21 (2005) 2459-2466
4. Brikas P., Kania B.F., Fioramonti J., and Budno L. Central and peripheral serotonergic influences on viscero-visceral inhibitory reflex during duodenal distension in sheep. Digest. Dis. Sci. 38 (1993) 1079-1086
5. Castaneda M.P., Wals C.A., Woroniecki R.P., Del Rio M., and Flynn J.T. Ventricular arrhythmia following short-acting nifedipine administration. Pediatr. Nephrol. 20 (2005) 1000-1002
6. 2+ removal on aiNA, aiK, and tension in cardiac Purkinje fibres. Am. J. Physiol. 251 (1986) C920-C927
7. De Witt C.R., and Waksmman J.C. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker activity. Toxicol. Rev. 23 (2004) 223-238
8. Diaz A., Florez J., Pazos A., and Hurle M.A. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain 86 (2000) 227-235
9. Dorgul A., Gardell L.R., Ossipov M.H., Tulunay F.C., Lai J., and Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105 (2003) 159-168
10. Fine P.G. Analgesia issues in palliative care: bone pain, controlled release opioids, managing opioid-induced constipation and nifedipine as an analgesic. J. Pain Palliative Care Pharmacother. 16 (2002) 93-97
11. Fleckenstein A. History of calcium antagonists. Circ. Res. 52 Suppl. 1 (1983) 3-16
12. 2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats. Neuropharmacology 42 (2002) 467-475
13. Gutierrez-Martin Y., Martin-Romero F.J., and Henao F. Store-operated calcium entrey in differentiated C2C12 skeletal muscle cells. Bichem. Biophys. Acta 1711 (2005) 33-40
14. Kania B.F. Adrenergic reactions of sheep rumen in vitro. Acta Physiol. Pol. 31 (1980) 341-348
15. Kania B.F. Adrenergic reactions of sheep rumen in vivo. Acta Physiol. Pol. 31 (1980) 349-356
16. Kania B.F., Brikas P., Bueno L., Fioramonti J., and Zaremba-Rutkowska M. The evaluation of the role of CCK in the opioid modulation of the motility of the gastrointestinal tract in sheep. J. Vet. Pharmacol. Ther. 22 (1999) 153-160
17. 1 central receptor antagonist prevented the intestinal stress symptoms in sheep. Pol. J. Vet. Sci. 5 (2002) 35-42
18. Katz A.M. Calcium channel diversity in the cardiovascular system. J. Am. Coll. Cardiol. 28 (1999) 522-528
19. Korte S.M., Bouws G.A.H., and Bohus B. Central actions of cortico-releasing hormone (CR-H) on behavioural, neuroendocrine and cardiovascular regulation: brain corticoid receptor involvement. Horm. Behav. 27 (1993) 167-183
20. Law for animal protection, 1997. Dz.U.R.P. Nr 11, 23th October 1997.
21. Le Beau A.P., and Mason D.R. The effects of chemically diverse range of calcium channel antagonists on the AVP-stimulated ACTH response in ovine corticotrophs. Cell Calcium 16 (2001) 47-58
22. 2+ uptake and energy supply of heep heart mitochondria in presence of some calcium antagonists. Res. Commun. Chem. Pathol. Pharmacol. 44 (1984) 499-502
23. Lia M., and Prado W.W. Effects of intrathecal L- and N-type calcium channel blockers on the antinociception evoked by opioid agonists in the rat tail flick test. Acta Physiol. Pharmacol. Ther. Latinoam. 49 (1999) 195-203
24. Long W., Zhao Y., Zhang L., and Longo L.D. Role of Ca(2+) channels in NE induced increase in [Ca(2+)](i) and tension in fetal and adult cerebral arteries. Am. J. Physiol. 277 (1999) R286-R294
25. Mahata M., Mahata S.K., Parmer R.J., and O'Connor D.T. Vesicular monoamine transport inhibitors. Hypertension 28 (1996) 414-420
26. Malmberg A.B., and Yaksh T.L. Effect of continuous intrathecal infusion of -conopeptides, N-type calcium channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60 (1995) 83-90
27. McBride S.D., and Cuddelford D. The putative welfare reducing effects of preventing equine stereotypic behaviour. Anim. Welfare 10 (2001) 173-189
28. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur. J. Pharmacol. 352 (1998) 189-197
29. Miljanich G.P., and Ramachandran J. Antagonists of neuronal calcium channels: Structure, function and therapeutic implications. Ann. Rev. Pharmacol. Toxicol. 35 (1995) 707-734
30. Mustafa S.M., Pilcher C.W., and Williams K.I. Cooling-induced contraction in ovine airways smooth muscle. Pharmacol. Res. 39 (1999) 113-123
31. Principles of laboratory animal care, 1985. NIH publication Nr 86-23, revised 1985.
32. Prough D.S., McLeske C.H., Poehling G.G., Koman L.A., Weeks D.B., Whitworth T., and Sembel E.L. Efficacy of oral nifedipine in the treatment of reflex sympathetic dystrophy. Anesthesiology 62 (1985) 796-799
33. Rang H.P., Dale M.M., and Ritter J.M. The heart. Pharmacology (1999), Churchill Livingstone, Edinbourgh, London 274-276
34. Roca G., Aguilar J.C., Gomar C., Mazo V., Costa J., and Vidal F. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment. Pain 68 (1996) 239-243
35. Rocchita G., Migheli R., Mura M.P., Grella G., Esposito G., Marchetti B., Miele E., Desole M.S., Miele M., and Serra P.A. Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: Role of extracellular Ca(2+) and L-type Ca(2+) channels. Brain Res. 1047 (2005) 18-29
36. Sadowski B., Sas, Swiderski T., and Trzasko M. Differentiation of opioid and non-opioid pain inhibitory mechanisms and of thermoregulation in mice selectively bred for high and low swim-stress induced analgesia. Analgesia 2 (1996) 211-218
37. Satoh T., Moriyama T., Kuriki H., and Karaki H. Calcium channel blocker-like action of reserpine in smooth muscle. Japan J. Pharmacol. 60 (1992) 291-293
38. Schleifer K.J., and Tot E. Molecular modeling study of diltiazem mimics at L-type calcium channels. Pharmacol. Res. 16 (1999) 1506-1513
39. Shimizu N., Kishioka S., Maeda T., Fukazawa Y., Yamamoto C., and Ozaki Yamamoto H. Role of pharmacokinetic effects in the potentiation of morphine analgesia by L-type calcium channel blockers in mice. J. Pharmacol. Sci. 94 (2004) 240-245
40. Sica D. Calcium channel blockers and the kidney. Clin. Cornestrone 6 (2004) 39-52
41. Sorraing J.M., Fioramonti J., and Bueno L. Central and peripheral serotonergic control of forestomach motility in sheep. J. Vet. Pharmacol. Ther. 8 (1985) 312-319
42. Stepinska J., Sadowski Z., Szajewski T., Banaszewski M., Wojciechowski D., Kraska T., Nartowicz E., and Kuch J. Calcium blocker therapy before myocardial infarction increases post-infarction short- and long-term mortality. Kardiologia Polska 57 (2002) 512-516
43. Straka, and Swanson A.L. Calcium channel antagonists: morbidity and mortality - what's the evidence?. Am. Fam. Physician 1 (1998) 1551-1556
44. Strome L., Parker T.A., Kinsella J.P., Rairigh R.L., and Abman S.H. Chronic hypertension impairs flow-induced vasodilatation and augments the myogenic response in fetal lung. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L56-L66
45. Sugiuchi N., Yazaki T., Ito H., Fujiwara C., and Horiguchi T. Anesthetic management of MIDCAB with high dose diltiazeme. Masui 51 (2002) 177-181 article in Japanese
46. Venegas H., and Schaible H.G. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 85 (2000) 9-18
47. Verma V., Mediratta P.K., and Sharma K.K. Potentiation of analgesia and reversal of tolerance to morphine by calcium channel blockers. Indian J. Exp. Biol. 39 (2001) 636-642
48. Wong C.H., Dey P., Yarmush J., Wu W.H., and Zbusek V.K. Nifedipine-induced analgesia after epidural injection in rats. Anesth. Analg. 79 (1994) 297-305
49. Yamagishi S., and Takuechi M. Nifedipine inhibits tumor necrosis factor-alpha-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cells. Drug Exp. Clin. Res. 31 (2005) 13-17
50. Zhang Q., Li J.X., Zheng J.W., Liu R.K., and Liang J.H. L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice. Eur. J. Pharmacol. 467 (2003) 145-150